Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marwan Imad Jihad"'
Publikováno v:
Journal of Advanced Pharmaceutical Technology & Research, Vol 14, Iss 3, Pp 274-279 (2023)
Cancer is a disease triggered by an uncontrolled proliferation of a cluster of cells, typically originating from a single cell. Sorafenib, a widely utilized pharmaceutical, has limitations in clinical use due to pharmacokinetic challenges and the dev
Externí odkaz:
https://doaj.org/article/fa1772a18d3041968e38f685ca120a84
Publikováno v:
Al-Mustansiriyah Journal of Pharmaceutical Sciences, Vol 23, Iss 2 (2023)
Novel therapeutics are desperately needed for the difficult-to-treat and very lethal malignancy known as hepatocellular carcinoma (HCC). The first drug now authorized for the treatment of individuals with advanced HCC is sorafenib. To find novel Vasc
Externí odkaz:
https://doaj.org/article/632e51b4a08543059f7dc1bc399e05c8
Publikováno v:
Al Mustansiriyah Journal of Pharmaceutical Sciences. 23:214-220
Novel therapeutics are desperately needed for the difficult-to-treat and very lethal malignancy known as hepatocellular carcinoma (HCC). The first drug now authorized for the treatment of individuals with advanced HCC is sorafenib. To find novel Vasc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d0eaaad5135f9ed1ca264a0e6fdf8c9
https://doi.org/10.32947/ajps.v23i2.1023
https://doi.org/10.32947/ajps.v23i2.1023